EDWARDS LIFESCIENCES CORP (1EW.MI) Fundamental Analysis & Valuation

BIT:1EW • US28176E1082

65.35 EUR
-5.41 (-7.65%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1EW.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

1EW gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. 1EW gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, 1EW is valued expensive at the moment. These ratings could make 1EW a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. 1EW.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1EW was profitable.
  • 1EW had a positive operating cash flow in the past year.
  • In the past 5 years 1EW has always been profitable.
  • 1EW had a positive operating cash flow in each of the past 5 years.
1EW.MI Yearly Net Income VS EBIT VS OCF VS FCF1EW.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • 1EW has a better Return On Assets (10.31%) than 89.55% of its industry peers.
  • With a decent Return On Equity value of 13.40%, 1EW is doing good in the industry, outperforming 77.61% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 12.50%, 1EW belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1EW is significantly above the industry average of 9.88%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 12.5%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1EW.MI Yearly ROA, ROE, ROIC1EW.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • 1EW's Profit Margin of 23.25% is amongst the best of the industry. 1EW outperforms 92.54% of its industry peers.
  • 1EW's Profit Margin has improved in the last couple of years.
  • 1EW has a Operating Margin of 27.73%. This is amongst the best in the industry. 1EW outperforms 97.01% of its industry peers.
  • 1EW's Operating Margin has been stable in the last couple of years.
  • 1EW has a better Gross Margin (78.19%) than 92.54% of its industry peers.
  • In the last couple of years the Gross Margin of 1EW has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
1EW.MI Yearly Profit, Operating, Gross Margins1EW.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. 1EW.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1EW is still creating some value.
  • Compared to 1 year ago, 1EW has less shares outstanding
  • The number of shares outstanding for 1EW has been reduced compared to 5 years ago.
  • 1EW has a better debt/assets ratio than last year.
1EW.MI Yearly Shares Outstanding1EW.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1EW.MI Yearly Total Debt VS Total Assets1EW.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • 1EW has an Altman-Z score of 11.49. This indicates that 1EW is financially healthy and has little risk of bankruptcy at the moment.
  • 1EW has a better Altman-Z score (11.49) than 92.54% of its industry peers.
  • The Debt to FCF ratio of 1EW is 0.75, which is an excellent value as it means it would take 1EW, only 0.75 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.75, 1EW belongs to the best of the industry, outperforming 91.04% of the companies in the same industry.
  • 1EW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • 1EW has a better Debt to Equity ratio (0.06) than 85.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 11.49
ROIC/WACC1.25
WACC9.99%
1EW.MI Yearly LT Debt VS Equity VS FCF1EW.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • 1EW has a Current Ratio of 4.00. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.00, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
  • 1EW has a Quick Ratio of 3.29. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.29, 1EW belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
1EW.MI Yearly Current Assets VS Current Liabilites1EW.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1EW.MI Growth Analysis

3.1 Past

  • 1EW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
  • Measured over the past 5 years, 1EW shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • 1EW shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
  • Measured over the past years, 1EW shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

  • 1EW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.40% yearly.
  • 1EW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1EW.MI Yearly Revenue VS Estimates1EW.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
1EW.MI Yearly EPS VS Estimates1EW.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1EW.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1EW is valuated quite expensively with a Price/Earnings ratio of 29.84.
  • 1EW's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.29. 1EW is around the same levels.
  • Based on the Price/Forward Earnings ratio of 25.83, the valuation of 1EW can be described as expensive.
  • 1EW's Price/Forward Earnings is on the same level as the industry average.
  • 1EW is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
1EW.MI Price Earnings VS Forward Price Earnings1EW.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1EW is valued a bit more expensive than 61.19% of the companies in the same industry.
  • 1EW's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 55.74
EV/EBITDA 22.46
1EW.MI Per share data1EW.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1EW may justify a higher PE ratio.
PEG (NY)23.47
PEG (5Y)4.18
EPS Next 2Y6.53%
EPS Next 3Y7.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1EW.MI Dividend Analysis

5.1 Amount

  • 1EW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1EW.MI Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

BIT:1EW (2/10/2026, 7:00:00 PM)

65.35

-5.41 (-7.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap37.92B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target82.88 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)1.89%
PT rev (3m)7%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-1.76%
EPS NY rev (1m)0.84%
EPS NY rev (3m)5.07%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)3.76%
Valuation
Industry RankSector Rank
PE 29.84
Fwd PE 25.83
P/S 7.58
P/FCF 55.74
P/OCF 43.83
P/B 4.37
P/tB 6.1
EV/EBITDA 22.46
EPS(TTM)2.19
EY3.35%
EPS(NY)2.53
Fwd EY3.87%
FCF(TTM)1.17
FCFY1.79%
OCF(TTM)1.49
OCFY2.28%
SpS8.63
BVpS14.96
TBVpS10.71
PEG (NY)23.47
PEG (5Y)4.18
Graham Number27.15
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 12.5%
ROICexc 18.63%
ROICexgc 29.56%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 11.49
F-Score6
WACC9.99%
ROIC/WACC1.25
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.27%
EPS Next 2Y6.53%
EPS Next 3Y7.87%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.15%
Revenue Next 3Y8.06%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.


What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.


How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.


What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 29.84 and the Price/Book (PB) ratio is 4.37.


What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?

The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 1.27% in the next year.